ArticleCancers2023

Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition.

Kentaro Tokumo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.